BioSpace News Archive

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 2019 Cantor Global Healthcare Conference on Thursday, October 3, 2019 at 9:30 am ET at the InterContinental New York Barclay Hotel in New York City.

Centene Corporation and WellCare Health Plans, Inc. announced that, in connection with the previously announced merger agreement between Centene and WellCare, a subsidiary of WellCare has entered into a definitive agreement under which Anthem, Inc. will acquire WellCare’s Missouri and Nebraska Medicaid plans.

GE Renewable Energy’s Grid Solutions business announced plans to invest tens of millions of dollars to expand its range of sulfur hexafluoride-free high-voltage substation equipment to include all key high-voltage levels by 2025.

VoP Report was recently published on the FDA website, highlights the results of the Externally-led Patient-Focused Drug Development (PFDD) Meeting [26-September-2019] NEW YORK , Sept. 26, 2019 /PRNewswire/ -- The Hereditary Neuropathy Foundation (HNF) is proud to share the Voice of the Patient (VoP) Report which was recently published on the FDA website. The report hi

BWX Technologies, Inc. announced that subsidiary BWXT ITG Canada, Inc., having received approval from the U.S. Food and Drug Administration on its abbreviated new drug application for its generic version of Indium In-111 Oxyquinoline Solution, is now making the product available for sale in the United States.

Gala Therapeutics, Inc. announced that clinical results and a patient case involving its RheOxTM Bronchial Rheoplasty system will be presented at the 2019 ERS International Congress, occurring Sept. 28 - Oct. 2, 2019 in Madrid, Spain.

Tetraphase Pharmaceuticals, Inc. announced that it will effect a 1-for-20 reverse stock split of its common stock that will be effective at 5:00 p.m. Eastern Time.

Sherlock Biosciences announced it has been awarded funding from the U.S. Defense Threat Reduction Agency to develop a rapid response platform for ultra-fast, ultra-sensitive and field-deployable diagnostics.

AVEO Oncology announced that Michael Bailey, president and chief executive officer, will present at the 2019 Cantor Fitzgerald Global Healthcare Conference in New York on Friday, October 4, 2019 at 10:05 a.m. Eastern Time.

KalVista Pharmaceuticals, Inc. announced that it will present at the Cantor Global Healthcare Conference on Thursday, October 3, 2019, at 10:05 a.m. ET in New York, NY.